| Product Code: ETC8889851 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Neuroblastoma Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Neuroblastoma Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Neuroblastoma Market - Industry Life Cycle |
3.4 Portugal Neuroblastoma Market - Porter's Five Forces |
3.5 Portugal Neuroblastoma Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.6 Portugal Neuroblastoma Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Portugal Neuroblastoma Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Portugal Neuroblastoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about neuroblastoma and its early detection in Portugal |
4.2.2 Technological advancements in diagnosis and treatment of neuroblastoma |
4.2.3 Growing investment in research and development of new therapies for neuroblastoma |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities for neuroblastoma treatment in Portugal |
4.3.2 High treatment costs associated with neuroblastoma therapies |
4.3.3 Lack of skilled healthcare professionals in the field of neuroblastoma in Portugal |
5 Portugal Neuroblastoma Market Trends |
6 Portugal Neuroblastoma Market, By Types |
6.1 Portugal Neuroblastoma Market, By Diagnostics |
6.1.1 Overview and Analysis |
6.1.2 Portugal Neuroblastoma Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.3 Portugal Neuroblastoma Market Revenues & Volume, By MIBG scan, 2021- 2031F |
6.1.4 Portugal Neuroblastoma Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.5 Portugal Neuroblastoma Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2 Portugal Neuroblastoma Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Portugal Neuroblastoma Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 Portugal Neuroblastoma Market Revenues & Volume, By Medications, 2021- 2031F |
6.2.4 Portugal Neuroblastoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.5 Portugal Neuroblastoma Market Revenues & Volume, By Radiation therapy, 2021- 2031F |
6.2.6 Portugal Neuroblastoma Market Revenues & Volume, By Stem cell transplant, 2021- 2031F |
6.2.7 Portugal Neuroblastoma Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3 Portugal Neuroblastoma Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Portugal Neuroblastoma Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.3.3 Portugal Neuroblastoma Market Revenues & Volume, By Ambulatory surgical centers, 2021- 2031F |
6.3.4 Portugal Neuroblastoma Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.3.5 Portugal Neuroblastoma Market Revenues & Volume, By Research centers, 2021- 2031F |
6.3.6 Portugal Neuroblastoma Market Revenues & Volume, By Others, 2021- 2031F |
7 Portugal Neuroblastoma Market Import-Export Trade Statistics |
7.1 Portugal Neuroblastoma Market Export to Major Countries |
7.2 Portugal Neuroblastoma Market Imports from Major Countries |
8 Portugal Neuroblastoma Market Key Performance Indicators |
8.1 Survival rates of neuroblastoma patients in Portugal |
8.2 Number of clinical trials and research studies conducted in Portugal for neuroblastoma |
8.3 Adoption rate of advanced neuroblastoma treatment technologies in Portugal |
9 Portugal Neuroblastoma Market - Opportunity Assessment |
9.1 Portugal Neuroblastoma Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.2 Portugal Neuroblastoma Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Portugal Neuroblastoma Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Portugal Neuroblastoma Market - Competitive Landscape |
10.1 Portugal Neuroblastoma Market Revenue Share, By Companies, 2024 |
10.2 Portugal Neuroblastoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here